
OrsoBiorevenue
Palo Alto, CaliforniaFounded 2021CEO Viktor Gauk
OrsoBio is a clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders including obesity, diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis.
OrsoBio revenue
OrsoBio has not published its revenue. Growjo puts it at about $2.2M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $2.2MEST | Growjo estimate |
OrsoBio CEO & employees
Viktor Gauk is CEO of OrsoBio. OrsoBio has 18 employees (September 2025, LinkedIn).
- Viktor GaukCEO
OrsoBio FAQ
What is OrsoBio's revenue?
Growjo estimates OrsoBio's revenue at about $2.2M a year (September 2025). The company hasn't published its own figure.
How many employees does OrsoBio have?
OrsoBio has 18 employees as of September 2025, according to LinkedIn.
Who is the CEO of OrsoBio?
Viktor Gauk is the CEO of OrsoBio.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun OrsoBio? Join the podcast